Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease

Author： Meerpohl H.G.   Sauerbrei W.   Kuhnle H.   Schumacher M.   Pfleiderer A.   German Ovarian Cancer Study Group GOCA  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.66, Iss.1, 1997-07, pp. : 75-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel/carboplatin with or without sorafenib in the first‐line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Cannon Research Institute

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 673-681

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Trial of Carboplatin, Paclitaxel, Etoposide, and Cyclophosphamide with Granulocyte Colony Stimulating Factor as First-Line Therapy for Patients with Advanced Epithelial Ovarian Cancer

By Tung N.   Berkowitz R.   Matulonis U.   Quartulli M.   Seiden M.   Kim Y.   Niloff J.   Cannistra S.A.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 271-277

Elsevier

Access to resources Recommend Favorite

Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients - 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin

By Dittrich C.   Sevelda P.   Salzer H.   Obermair A.   Speiser P.   Breitenecker G.   Schemper M.   Kaider A.   on behalf of the Austrian Ovarian Cancer Study Group  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1129-1140

Elsevier

Access to resources Recommend Favorite

Kinetic Modeling and Efficacy of Intraperitoneal Paclitaxel Combined with Intravenous Cyclophosphamide and Carboplatin as First-Line Treatment in Ovarian Cancer

By Hofstra L.S.   Bos A.M.E.   de Vries E.G.E.   van der Zee A.G.J.   Willemsen A.T.M.   Rosing H.   Beijnen J.H.   Mulder N.H.   Aalders J.G.   Willemse P.H.B.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 517-523

Academic Press

Access to resources Recommend Favorite

Systematic Review of First-Line Chemotherapy for Newly Diagnosed Postoperative Patients with Stage II, III, or IV Epithelial Ovarian Cancer

By Covens A.   Carey M.   Bryson P.   Verma S.   Fung Kee Fung M.   Johnston M.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 71-80

Elsevier

Access to resources Recommend Favorite